Weatherall D J, Provan A B
Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, UK.
Lancet. 2000 Apr 1;355(9210):1169-75. doi: 10.1016/s0140-6736(00)02073-0.
Examination of the genetic mechanisms underlying the thalassaemias has led to a clearer understanding of the control of eukaryotic genes in general. Inherited disorders of haemoglobin synthesis are an important cause worldwide of morbidity and mortality, and place a large burden on patients, families, and ultimately communities. The haemoglobin disorders can be controlled, by counselling and prenatal diagnosis. Treatment is usually symptomatic, though bone-marrow transplantation for beta-thalassaemia may be successful in suitable patients.